Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c00916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Yurina Araki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, Graduate School of Science, Osaka Metropolitan University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cell Movement, Cell-Penetrating Peptides, Serum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Naito Foundation, Takeda Science Foundation, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Breast cancer remains one of the most prevalent cancers among women, with triple-negative breast cancer (TNBC), lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, accounting for approximately 15-20% of all patients with breast cancer. TNBC is notably aggressive, with a high invasive, metastatic, and recurrence potential. In this study, we found that the migration and invasion capabilities of MDA-MB-231 cells, derived from human TNBC, were strongly influenced by the serum concentration. Transwell assays revealed that TNBC cell migration varied depending on the fetal bovine serum (FBS) level, with an optimal concentration that substantially enhanced migration and invasion. In contrast, non-TNBC MCF-7 cells exhibited no such serum-dependent migration pattern. In addition to data-independent acquisition (DIA) phosphoproteomic analysis for understanding the mechanisms, the cellular uptake of the flock house virus coat (35-49) peptide, a type of arginine-rich cell-penetrating peptide with serum-dependent cellular uptake efficacy, was significantly increased under the optimal serum conditions, which induces cell migration, leading to efficient delivery of apoptosis-inducible peptide and TNBC-killing activity. Our findings highlight the critical role of serum concentration in regulating TNBC behavior and offer insights into leveraging serum-responsive delivery systems for targeted breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, Graduate School of Science, Osaka Metropolitan University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan.
- Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien Kyuban-cho, Nishinomiya, Hyogo 663-8179, Japan.
- Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, Japan.
- Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto 611-0011, Japan.
- Human Biomimetic System RIKEN Hakubi Research Team, RIKEN Center for Biosystems Dynamics Research (BDR), 6-6-1 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
ORCID-Profile: Tomoka Takatani-Nakase, Hisaaki Hirose, Yoshimasa Kawaguchi, Shiroh Futaki, Masaya Hagiwara, Ikuhiko Nakase
Förderung
- Naito Foundation
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- Osaka Metropolitan University
Zitieren
APA
Araki, Y., Takatani-Nakase, T., Ninomiya, S., Matsumoto, M., Hirose, H., Kawaguchi, Y., Fujiwara, D., Michigami, M., Katoh, H., Wada, T., Futaki, S., Fujii, I., Hagiwara, M., & Nakase, I. (2026). Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00916
Vancouver
Araki Y, Takatani-Nakase T, Ninomiya S, Matsumoto M, Hirose H, Kawaguchi Y, et al. Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00916
BibTeX
@article{Araki2026,
author = {Araki, Yurina and Takatani-Nakase, Tomoka and Ninomiya, Sohei and Matsumoto, Mitsuyo and Hirose, Hisaaki and Kawaguchi, Yoshimasa and Fujiwara, Daisuke and Michigami, Masataka and Katoh, Hironori and Wada, Takehiko and Futaki, Shiroh and Fujii, Ikuo and Hagiwara, Masaya and Nakase, Ikuhiko},
title = {Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c00916}
}
EUVIMED